| Literature DB >> 30002013 |
Muhammed Olanrewaju Afolabi1, Stuart Rennie2,3, Denise Dion Hallfors4, Tracy Kline5, Susannah Zeitz4,6, Frederick S Odongo7, Nyaguara O Amek7, Winnie K Luseno4.
Abstract
OBJECTIVE: To adapt and validate a questionnaire originally developed in a research setting for assessment of comprehension of consent information in a different cultural and linguistic research setting.Entities:
Keywords: Africa; informed consent; tool; understanding; validation
Mesh:
Year: 2018 PMID: 30002013 PMCID: PMC6082480 DOI: 10.1136/bmjopen-2018-021613
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographic characteristics of study participants, Kenya, 2017
| Demographics | Adolescents | Young adults | Parents |
| Age | |||
| Median | 16 | 18 | 42 |
| Range | 15–17 | 18–19 | 23–95 |
| IQR | 15–16 | 18–19 | 34–53 |
| Gender | |||
| Male | 60 (56.1%) | 18 (50%) | 22 (23.9%) |
| Female | 47 (43.9%) | 18 (50%) | 70 (76.1%) |
| Currently enrolled in school: N (%) | 105 (98.1%) | 26 (72.2%) | N/A |
| Highest level of education: N (%) | |||
| Never gone to school | 0 (0%) | 0 (0%) | 6 (6.5%) |
| Did not complete primary (<Std/Class 8) | 72 (67.3%) | 5 (13.9%) | 37 (40.2%) |
| Completed primary (Std/Class 8) | 10 (9.3%) | 7 (19.4%) | 24 (26.1%) |
| Did not complete secondary (<Form 4) | 25 (23.4%) | 24 (66.7%) | 10 (10.9%) |
| Completed secondary (Form 4) | 0 (0%) | 0 (0%) | 12 (13.0%) |
| College or university | 0 (0%) | 0 (0%) | 3 (3.3%) |
| Attended vocational school: N(%) | 0 (0%) | 2 (5.6%) | 12 (13.0%) |
| Religion: N(%) | |||
| Roman Catholic | 16 (15.0%) | 4 (11.1%) | 16 (17.4%) |
| Protestant/other Christian | 90 (84.1%) | 31 (86.1%) | 76 (82.6%) |
| Muslim | 0 (0%) | 1 (2.8%) | 0 (0%) |
| No religion | 1 (0.9%) | 0 (0%) | 0 (0%) |
| Attending religious services once/week or more: N (%) | 39 (36.4%) | 20 (55.6%) | 52 (56.5%) |
| Relationship with adolescent: N(%) | |||
| Parent | N/A | N/A | 65 (70.7%) |
| Other | N/A | N/A | 27 (29.3%) |
| Staff present at consenting: N(%) | N/A | N/A | 43 (46.7%) |
Ceiling and floor percentages by response group.
| Questions with more than 80% correct (ceiling) | Adolescents (age 15–17 years; n=107) | Young adults (age 18–19 years; n=36) | Parents (n=92) |
| T-shirt for participation | 93.5 | 97.2 | 80.4† |
| Study activities for youth | 91.6 | 91.7 | N/A |
| HIV test results disclosure | 94.4 | 94.4 | 90.2 |
| Voluntary withdrawal | N/A | 94.4 | 85.9 |
| Decisions for study participation | N/A | 88.9 | N/A |
| What happens if you stop study participation | N/A | 86.1 | N/A |
| Purpose of conducting study | N/A | 88.9 | N/A |
| Voluntary participation | N/A | 100 | 93.5 |
*Per cent only shown if ceiling/floor cut-off met.
†Parents who consented without staff present would not have met criterion for ceiling; parents who consented with staff would not meet criterion for floor.
‡(open) denotes open-ended questions, (response range=0–4). These were dichotomised for floor/ceiling analysis: 0=0–1, 1=2–4.
N/A, less than 80% of the sample (by population) got these items correct (upper panel) or incorrect (lower panel).
HCT, HIV Counselling and Testing.
Test-retest correlations for questions common to all and specific to adolescents, young adults and parents (n=74)*
| Question | N | Tetrachoric/polychoric |
| Have you been given the name and phone number of the person to contact if you have any questions about the study? | 74 | 0.86 |
| Will you receive a T-shirt for taking part in the study? | 74 | 0.6 |
| How were participants selected into different groups in this study? | 74 | 0.57 |
| In your own words, can you tell me what the purpose of the research study is? (open) | 73 | −0.92 |
| What is the difference between taking part in this study and going to the clinic for voluntary HIV testing? (open) | 72 | 0.87 |
| Are there any bad things that could happen by taking part in this study? If yes, what are they? (open) | 70 | 0.9 |
| If you had a question or concern about the study, who would you call? (open) | 74 | 0.72 |
| Have you been told you can withdraw from the study at any time? | 45 | 0.75 |
| During the study, will anyone not working with KEMRI or the nearest clinic know about your health information? | 44 | 0.62 |
| At what point can you leave the study? | 45 | 0.94 |
| What does it mean when you sign the study consent form?† | 45 | 0.19 |
| What happens if you decide to stop taking part in the study? | 45 | 0.86 |
| Which of the following describes best why the study is being done? | 45 | 0.51 |
| Which of these activities were you asked to take part in today? | 45 | 0.62 |
| Will you be told your HIV test results during the study?‡ | 45 | N/A |
| Other activities you might be invited to do? | 45 | 0.6 |
| If you test positive for HIV, will you be offered free treatments? | 45 | 0.66 |
| If you are invited to participate in additional interviews for this study, how will you be compensated for your participation? | 45 | 0.73 |
| Which describes one of the main risks involved in the study? | 45 | 0.67 |
| Which describes the main benefit of taking part in the study?† | 45 | 0.26 |
| In your own words, can you tell me what makes you eligible to participate in this study? (open) | 45 | 0.9 |
| How long will you be involved in the study? (open) | 45 | 0.86 |
| What will you be asked to do as a participant in the study after you receive your HIV test results? (open)† | 45 | 0.47 |
| If you want to join the study, but your parent/guardian does not agree, can you still join the study? | 33 | 0.64 |
| If your parents wants you to join the study, but you do not want to, are you still allowed to refuse?† | 33 | 0.45 |
| Have you been told that you can freely decide whether you will take part in this study?‡ | 12 | N/A |
| How did you decide to join the study?‡ | 12 | N/A |
*Post hoc analysis with cross-tabulations were used to further explore the low correlation coefficient.
†A correlation coefficient could not be obtained for this item. Cross-tabulations were used to examine relationships within the data.
‡For complete questions with responses, see online supplementary appendix.
KEMRI, Kenya Medical Research Institute.